Gobbi Riccardo, Baiardi Simone, Mondini Susanna, Cerritelli Luca, Piccin Ottavio, Scaramuzzino Giuseppe, Milano Francesca, Melotti Maria Rita, Mordini Francesco, Pirodda Antonio, Cirignotta Fabio, Sorrenti Giovanni
Department of Head, Neck and Sensory System, Otorhinolaryngolologic Clinic, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Neurology Unit, Department of Head, Neck and Sensory System, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy3Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
JAMA Otolaryngol Head Neck Surg. 2017 May 1;143(5):459-465. doi: 10.1001/jamaoto.2016.3964.
Drug-induced sleep endoscopy is a diagnostic technique that allows dynamic evaluation of the upper airway during artificial sleep. The lack of a standardized procedure and the difficulties associated with direct visual detection of obstructive events result in poor intraobserver and interobserver reliability, especially when otolaryngology surgeons not experienced in the technique are involved.
To describe a drug-induced sleep endoscopy technique implemented with simultaneous polygraphic monitoring of cardiorespiratory parameters (DISE-PG) in patients with a diagnosis of obstructive sleep apnea syndrome and discuss the technique's possible advantages compared with the standard procedure.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study included 50 consecutive patients with obstructive sleep apnea syndrome who underwent DISE-PG from March 1, 2013, to June 30, 2014. A standard protocol was adopted, and all the procedures were carried out in an operation room by an experienced otolaryngology surgeon under the supervision of an anesthesiologist. Endoscopic and polygraphic obstructive respiratory events were analyzed offline in a double-blind setting and randomized order.
The feasibility and safety of the DISE-PG technique, as well as its sensitivity in detecting respiratory events compared with that of the standard drug-induced sleep endoscopy procedure.
All 50 patients (43 men and 7 women; mean [SD] age, 51.1 [12.1] years) underwent DISE-PG without technical problems or patient difficulties regarding the procedure. As expected, polygraphic scoring was more sensitive than endoscopic scoring in identifying obstructive events (mean [SD] total events, 13.3 [6.8] vs 5.3 [3.6]; mean [SD] difference, 8.8 [5.6]; 95% CI, 7.3 to 10.4; Cohen d, -1.5). This difference was most pronounced in patients with a higher apnea-hypopnea index (AHI) at baseline (mean [SD] difference for AHI >30, 27.1% [31.0%]; 95% CI, -36.2% to 90.4%; Cohen d, 0.2; for AH I >40, 76.0% [35.5%]; 95% CI, 4.6% to 147.4%; Cohen d, 0.5; for AHI >50, 92.2% [37.2%]; 95% CI, 17.3% to 167.1%; Cohen d, 0.6) and a high percentage of hypopneas (≥75% of all obstructive events) at baseline (mean [SD] difference, 20.2% [5.4%]; 95% CI, 9.2% to 31.3%; Cohen d, 1.1). No other anthropomorphic or polygraphic features at baseline were associated with the differences between the DISE-PG and baseline home sleep apnea test.
The DISE-PG technique is feasible, safe, and more sensitive at detecting an obstructed breathing pattern than is drug-induced sleep endoscopy alone. The DISE-PG technique could be helpful for accurate comprehension of upper airway obstructive dynamics (ie, degree of obstruction and multilevel pattern) and a nonobstructive breathing pattern (ie, central apneas).
药物诱导睡眠内镜检查是一种诊断技术,可在人工睡眠期间对上气道进行动态评估。缺乏标准化程序以及直接视觉检测阻塞性事件存在困难,导致观察者内和观察者间的可靠性较差,尤其是当涉及到对该技术不熟练的耳鼻喉科外科医生时。
描述一种在诊断为阻塞性睡眠呼吸暂停综合征的患者中实施的药物诱导睡眠内镜检查技术,并同时对心肺参数进行多导睡眠监测(DISE-PG),并讨论该技术与标准程序相比可能具有的优势。
设计、地点和参与者:这项前瞻性队列研究纳入了2013年3月1日至2014年6月30日期间连续接受DISE-PG的50例阻塞性睡眠呼吸暂停综合征患者。采用标准方案,所有程序均在手术室由经验丰富的耳鼻喉科外科医生在麻醉医生的监督下进行。内镜和多导睡眠监测的阻塞性呼吸事件在双盲环境下按随机顺序进行离线分析。
DISE-PG技术的可行性和安全性,以及与标准药物诱导睡眠内镜检查程序相比,其在检测呼吸事件方面的敏感性。
所有50例患者(43例男性和7例女性;平均[标准差]年龄为51.1[12.1]岁)均接受了DISE-PG,在操作过程中未出现技术问题或患者困难。正如预期的那样,在识别阻塞性事件方面,多导睡眠监测评分比内镜评分更敏感(平均[标准差]总事件数,13.3[6.8]对5.3[3.6];平均[标准差]差异,8.8[5.6];95%置信区间,7.3至10.4;Cohen d,-1.5)。这种差异在基线时呼吸暂停低通气指数(AHI)较高的患者中最为明显(AHI>30时的平均[标准差]差异,27.1%[31.0%];95%置信区间,-36.2%至90.4%;Cohen d,0.2;AHI>40时,76.0%[35.5%];95%置信区间,4.6%至147.4%;Cohen d,0.5;AHI>50时,92.2%[37.2%];95%置信区间,17.3%至167.1%;Cohen d,0.6)以及基线时低通气百分比较高(占所有阻塞性事件的≥75%)的患者中(平均[标准差]差异,20.2%[5.4%];95%置信区间,9.2%至31.3%;Cohen d,1.1)。基线时的其他人体测量或多导睡眠监测特征与DISE-PG和基线家庭睡眠呼吸暂停测试之间的差异无关。
DISE-PG技术是可行、安全的,并且在检测阻塞性呼吸模式方面比单独的药物诱导睡眠内镜检查更敏感。DISE-PG技术有助于准确理解上气道阻塞动力学(即阻塞程度和多平面模式)和非阻塞性呼吸模式(即中枢性呼吸暂停)。